6 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
and CKD EMPA-REG ... outcomes in HFrEF on GDMT ... outcomes in HFrEF on GDMT ... visualabstract #table ... #CVD #CKD
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... -4 inhibitors SGLT2 ... Improved outcomes in CKD ... #table #comparison
Adjusted Pain Medication Dosing based on GFR

#Renal #Dosing #Pain #Pharmacology #Opiates #CKD #Gabapentin #Table
Adjusted Pain Medication ... Renal #Dosing #Pain ... Pharmacology #Opiates #CKD ... #Gabapentin #Table
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
Medical Therapy (GDMT ... ) in HFrEF and CKD ... diuretics, MRA, SGLT2i ... Chronotropes • Medications ... #CKD #HFrEF #management
Intern Pocket Cards - Pharmacologic Pain Management Options
Anti-inflammatory:
 • Acetaminophen (24 hours: < 3-4g in healthy
Pharmacologic Pain ... adults, <3g in CKD ... avoid NSAIDs if CKD ... pocketcardset #Pain ... #Ladder #medications
Dilated Common Bile Duct on POCUS
50's yo patient with RUQ abd pain. Vitals stable/afebrile. Labs: WBC
Common Bile Duct on POCUS ... pain. ... Vitals stable/afebrile ... mass in distal CBD ... RJonesSonoEM #Dilated #CBD